Tronox sees roughly $25M–$50M free cash outflow in 2026
Fourth-quarter Adjusted EBITDA is forecast at $80 million to $90 million, while full-year free cash flow is expected to be a use of cash.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Tronox Holdings plc (TROX) reported third-quarter 2026 revenue of $827 million, up 18% year over year, and Adjusted EBITDA of $101 million, up 36%; adjusted EBITDA margin was 12.2%, versus 10.6%. Net loss attributable to Tronox was $55 million, compared with $99 million a year earlier, and free cash flow was $5 million.
Management attributed EBITDA performance mainly to higher selling prices, partly offset by higher production and freight costs and unfavorable currency effects. It expects fourth-quarter Adjusted EBITDA of $80 million to $90 million and positive free cash flow of $20 million to $45 million; full-year 2026 free cash flow is expected to be a use of approximately $25 million to $50 million. The fourth-quarter EBITDA outlook reflects approximately $15 million to $20 million of higher-than-expected input costs.
At September 30, 2026, available liquidity was $509 million and the net leverage ratio was 10.5x on a trailing-twelve-month basis. The cost improvement program remains on track to deliver more than $175 million of run-rate savings by year-end 2026. Tronox and JX Advanced Metals will fund approximately $32 million in aggregate on a 50/50 basis for rare-earth studies and development of a U.S.-based pilot facility.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointQ3 2026 revenue rose 18% year over year to $827 million.
- Moderate pointQ3 2026 Adjusted EBITDA rose 36% year over year to $101 million.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.Full-year 2026 free cash flow: expected cash use of approximately $25 million to $50 million.
Filing Explained
The release says Tronox’s next significant debt maturity is not until 2029, its term loans and bonds have no financial covenants, and it does not expect to trigger the U.S. revolving credit facility’s springing covenant.
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
free cash flow financial
net leverage ratio financial
anti-dumping duties regulatory
rare earth oxides technical
Earnings Snapshot
Fourth-quarter 2026 Adjusted EBITDA is expected to be $80 million to $90 million, with positive free cash flow of $20 million to $45 million. Full-year 2026 free cash flow is expected to be a use of approximately $25 million to $50 million.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were TROX's Q3 2026 revenue and Adjusted EBITDA?
What is TROX's fourth-quarter 2026 earnings and cash-flow outlook?
How much debt and liquidity did TROX report at September 30, 2026?
What does TROX's agreement with JX Advanced Metals fund?
AI-generated analysis. How Rhea-AI works. Not financial advice.
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
Laporte Road, Stallingborough
|
||
|
|
Grimsby, North East Lincolnshire, DN40 2PR, UK
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Earnings Release, dated November 4, 2026.
|
|
|
104
|
Inline XBRL for the cover page of this Current Report on Form 8-K.
|
|
TRONOX HOLDINGS PLC
|
|||
|
Date: November 5, 2026
|
By:
|
/s/ Jeffrey N. Neuman
|
|
|
Name: Jeffrey N. Neuman
|
|||
|
Title: Senior Vice President, General Counsel and Secretary
|

| • |
Revenue of $827 million, an 18% increase compared to the prior year and a 5% decrease compared to the prior quarter
|
| • |
Income from operations of $12 million; net loss attributable to Tronox of $55 million; and adjusted net loss attributable to Tronox was $54 million (non-GAAP)
|
| • |
GAAP diluted loss per share was $0.34; Adjusted diluted loss per share was $0.34 (non-GAAP)
|
| • |
Adjusted EBITDA of $101 million; Adjusted EBITDA margin of 12.2% (non-GAAP)
|
| • |
Capital expenditures of $57 million
|
| • |
Generated free cash flow of $5 million (non-GAAP)
|
| • |
Expect Q4 2026 TiO2 volumes to decline sequentially in the high-single to low double-digit percentage range, primarily driven by seasonality
|
| • |
Expect Q4 2026 zircon volume levels to soften moderately sequentially, primarily due to inventory availability
|
| • |
Expect Q3 TiO2 pricing gains to be sustained in Q4 and zircon pricing to increase sequentially in the mid-single-digit percentage range
|
| • |
Q4 2026 Adjusted EBITDA expected to be $80-$90 million
|
| • |
Expect free cash flow to be a source of $20-$45 million for Q4 2026, resulting in a free cash flow use of $25-50 million for full year 2026, updated from previous expectations
primarily due to the unforeseen prolonged conflict in the Middle East, driving unanticipated raw material price headwinds and weaker sales volumes
|
| |
1 | Page
|
|
($M unless otherwise noted)
|
Q3 2026
|
Q3 2025
|
Y-o-Y%∆
|
|
Q2 2026
|
Q-o-Q%∆
|
|
|||||||||||
|
Revenue
|
$
|
827 |
$
|
699 |
18
|
%
|
$
|
868
|
(5)
|
%
|
||||||||
|
TiO2
|
$
|
653
|
$
|
550
|
19
|
%
|
$
|
700 | (7) |
%
|
||||||||
|
Zircon
|
$
|
93
|
$
|
59 |
58
|
%
|
$
|
97
|
(4) |
%
|
||||||||
|
Other products
|
$
|
81
|
$
|
90 |
(10
|
)%
|
$
|
71
|
14 |
%
|
||||||||
|
Income (loss) from operations
|
$
|
12
|
|
$
|
(43
|
)
|
n/
|
m
|
$
|
(21
|
)
|
n/
|
m
|
|||||
|
Net (loss) attributable to Tronox
|
$
|
(55
|
)
|
$
|
(99
|
)
|
n/
|
m
|
$
|
(171
|
)
|
n/
|
m
|
|||||
|
GAAP diluted (loss) per share
|
$
|
(0.34
|
)
|
$
|
(0.63
|
)
|
n/
|
m
|
$
|
(1.07
|
)
|
n/
|
m
|
|||||
|
Adjusted diluted (loss) per share
|
$
|
(0.34
|
)
|
$
|
(0.46
|
)
|
n/
|
m
|
$
|
(0.51
|
)
|
n/
|
m
|
|||||
|
Adjusted EBITDA
|
$
|
101
|
$
|
74 |
36
|
%
|
$
|
73 |
38
|
%
|
||||||||
|
Adjusted EBITDA Margin %
|
12.2
|
%
|
10.6
|
%
|
160
|
bps |
8.4
|
%
|
380
|
bps | ||||||||
|
Free cash flow
|
$
|
5 |
$
|
(137
|
)
|
n/
|
m
|
$
|
60
|
|
n/
|
m
|
|
Y-o-Y % ∆
|
Q-o-Q % ∆
|
|||||
|
Volume
|
Price / Mix
|
FX
|
Volume
|
Price / Mix
|
FX
|
|
|
TiO2
|
10%
|
9%
|
0%
|
(11)%
|
4%
|
0%
|
|
Zircon
|
49%
|
9%
|
—
|
(13)%
|
9%
|
—
|
| |
2 | Page
|
| |
3 | Page
|
| |
4 | Page
|
| |
5 | Page
|
| |
6 | Page
|
| |
7 | Page
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
Net sales
|
$
|
827
|
$
|
699
|
$
|
2,455
|
$
|
2,168
|
||||||||
|
Cost of goods sold
|
750
|
647
|
2,279
|
1,938
|
||||||||||||
|
Gross profit
|
77
|
52
|
176
|
230
|
||||||||||||
|
Restructuring and other charges
|
—
|
25
|
18
|
153
|
||||||||||||
|
Selling, general and administrative expenses
|
65
|
70
|
208
|
216
|
||||||||||||
|
Income (Loss) from operations
|
12
|
(43
|
)
|
(50
|
)
|
(139
|
)
|
|||||||||
|
Interest expense
|
(56
|
)
|
(48
|
)
|
(165
|
)
|
(135
|
)
|
||||||||
|
Interest income
|
1
|
1
|
3
|
4
|
||||||||||||
|
Other expense, net
|
(7
|
)
|
(2
|
)
|
(9
|
)
|
(9
|
)
|
||||||||
|
Loss before income taxes
|
(50
|
)
|
(92
|
)
|
(221
|
)
|
(279
|
)
|
||||||||
|
Income tax provision
|
(6
|
)
|
(8
|
)
|
(112
|
)
|
(17
|
)
|
||||||||
|
Net loss
|
(56
|
)
|
(100
|
)
|
(333
|
)
|
(296
|
)
|
||||||||
|
Net loss attributable to noncontrolling interest
|
(1
|
)
|
(1
|
)
|
(4
|
)
|
(2
|
)
|
||||||||
|
Net loss attributable to Tronox Holdings plc
|
$
|
(55
|
)
|
$
|
(99
|
)
|
$
|
(329
|
)
|
$
|
(294
|
)
|
||||
|
Loss per share:
|
||||||||||||||||
|
Basic
|
$
|
(0.34
|
)
|
$
|
(0.63
|
)
|
$
|
(2.06
|
)
|
$
|
(1.85
|
)
|
||||
|
Diluted
|
$
|
(0.34
|
)
|
$
|
(0.63
|
)
|
$
|
(2.06
|
)
|
$
|
(1.85
|
)
|
||||
|
Weighted average shares outstanding, basic (in thousands)
|
159,701
|
158,600
|
159,524
|
158,439
|
||||||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,701
|
158,600
|
159,524
|
158,439
|
||||||||||||
|
Other Operating Data:
|
||||||||||||||||
|
Capital expenditures
|
57
|
80
|
169
|
273
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
76
|
75
|
227
|
220
|
||||||||||||
| |
8 | Page
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2026
|
2025
|
2026
|
2025
|
|||||||||||||
|
Net loss attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
(55
|
)
|
$
|
(99
|
)
|
$
|
(329
|
)
|
$
|
(294
|
)
|
||||
|
Gain on sale of Fuzhou (a)
|
—
|
—
|
(20
|
)
|
—
|
|||||||||||
|
Restructuring and other charges (b)
|
—
|
25
|
18
|
150
|
||||||||||||
|
Tax valuation allowance (c)
|
—
|
—
|
103
|
—
|
||||||||||||
|
Other (d)
|
1
|
2
|
4
|
3
|
||||||||||||
|
Adjusted net loss attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
(54
|
)
|
$
|
(72
|
)
|
$
|
(224
|
)
|
$
|
(141
|
)
|
||||
|
Diluted net loss per share (U.S. GAAP)
|
$
|
(0.34
|
)
|
$
|
(0.63
|
)
|
$
|
(2.06
|
)
|
$
|
(1.85
|
)
|
||||
|
Gain on sale of Fuzhou, per share
|
—
|
—
|
(0.13
|
)
|
—
|
|||||||||||
|
Restructuring and other charges, per share
|
—
|
0.16
|
0.12
|
0.94
|
||||||||||||
|
Tax valuation allowance, per share
|
—
|
—
|
0.65
|
—
|
||||||||||||
|
Other, per share
|
—
|
0.01
|
0.02
|
0.02
|
||||||||||||
|
Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) (1)
|
$
|
(0.34
|
)
|
$
|
(0.46
|
)
|
$
|
(1.40
|
)
|
$
|
(0.89
|
)
|
||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,701
|
158,600
|
159,524
|
158,439
|
||||||||||||
| |
9 | Page
|
|
September 30, 2026
|
December 31, 2025
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
136
|
$
|
199
|
||||
|
Restricted cash
|
18
|
12
|
||||||
|
Accounts receivable (net of allowance for credit losses of $1 and $1 as of September 30, 2026 and December 31, 2025,
respectively)
|
348
|
289
|
||||||
|
Inventories, net
|
1,435
|
1,652
|
||||||
|
Prepaid and other assets
|
176
|
112
|
||||||
|
Income taxes receivable
|
2
|
1
|
||||||
|
Total current assets
|
2,115
|
2,265
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
1,978
|
2,007
|
||||||
|
Mineral leaseholds, net
|
588
|
608
|
||||||
|
Intangible assets, net
|
197
|
214
|
||||||
|
Lease right of use assets, net
|
175
|
173
|
||||||
|
Deferred tax assets
|
723
|
833
|
||||||
|
Other long-term assets
|
115
|
117
|
||||||
|
Total assets
|
$
|
5,891
|
$
|
6,217
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
437
|
$
|
481
|
||||
|
Accrued liabilities
|
239
|
274
|
||||||
|
Short-term lease liabilities
|
24
|
22
|
||||||
|
Obligations under inventory financing arrangement
|
49
|
50
|
||||||
|
Short-term debt
|
47
|
51
|
||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
Income taxes payable
|
3
|
2
|
||||||
|
Total current liabilities
|
838
|
919
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
3,116
|
3,132
|
||||||
|
Pension and postretirement healthcare benefits
|
79
|
81
|
||||||
|
Asset retirement obligations
|
213
|
198
|
||||||
|
Environmental liabilities
|
19
|
39
|
||||||
|
Long-term lease liabilities
|
152
|
148
|
||||||
|
Deferred tax liabilities
|
211
|
208
|
||||||
|
Other long-term liabilities
|
109
|
43
|
||||||
|
Total liabilities
|
4,737
|
4,768
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 159,704,662 shares issued and outstanding at September 30,
2026 and 158,557,858 shares issued and outstanding at December 31, 2025
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,095
|
2,103
|
||||||
|
(Accumulated deficit) retained earnings
|
(299
|
)
|
30
|
|||||
|
Accumulated other comprehensive loss
|
(673
|
)
|
(717
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,125
|
1,418
|
||||||
|
Noncontrolling interest
|
29
|
31
|
||||||
|
Total equity
|
1,154
|
1,449
|
||||||
|
Total liabilities and equity
|
$
|
5,891
|
$
|
6,217
|
||||
| |
10 | Page
|
|
Nine Months Ended September 30,
|
||||||||
|
2026
|
2025
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net loss
|
$
|
(333
|
)
|
$
|
(296
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
227
|
220
|
||||||
|
Deferred income taxes
|
109
|
14
|
||||||
|
Share-based compensation expense
|
17
|
14
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
9
|
7
|
||||||
|
Restructuring and other charges
|
18
|
153
|
||||||
|
Other non-cash items affecting net loss
|
23
|
43
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in accounts receivable, net of allowance for credit losses
|
(59
|
)
|
(24
|
)
|
||||
|
Decrease (increase) in inventories, net
|
214
|
(73
|
)
|
|||||
|
Decrease in prepaid and other assets
|
-
|
39
|
||||||
|
Restructuring payments
|
(35
|
)
|
(57
|
)
|
||||
|
Decrease in accounts payable and accrued liabilities
|
(73
|
)
|
(70
|
)
|
||||
|
Net changes in income tax payables and receivables
|
1
|
(2
|
)
|
|||||
|
Changes in other non-current assets and liabilities
|
(19
|
)
|
(29
|
)
|
||||
|
Cash provided by (used in) operating activities
|
99
|
(61
|
)
|
|||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(169
|
)
|
(273
|
)
|
||||
|
Loans
|
-
|
15
|
||||||
|
Proceeds from dispositions and asset sales
|
15
|
3
|
||||||
|
Cash used in investing activities
|
(154
|
)
|
(255
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(102
|
)
|
(136
|
)
|
||||
|
Repayments of long-term debt
|
(23
|
)
|
(21
|
)
|
||||
|
Repayments of sale and leaseback transactions
|
(2
|
)
|
-
|
|||||
|
Repayments of inventory financing arrangement
|
(100
|
)
|
-
|
|||||
|
Proceeds from inventory financing arrangement
|
99
|
50
|
||||||
|
Proceeds from sale and leaseback transaction
|
75
|
-
|
||||||
|
Proceeds from short-term debt
|
80
|
100
|
||||||
|
Proceeds from long-term debt
|
-
|
400
|
||||||
|
Debt issuance costs
|
(2
|
)
|
(7
|
)
|
||||
|
Sale and leaseback transaction costs
|
(1
|
)
|
-
|
|||||
|
Dividends paid
|
(24
|
)
|
(40
|
)
|
||||
|
Restricted stock and performance-based shares settled in cash for withholding taxes
|
-
|
(1
|
)
|
|||||
|
Cash provided by financing activities
|
-
|
345
|
||||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
(2
|
)
|
5
|
|||||
|
Net (decrease) increase in cash and cash equivalents and restricted cash
|
(57
|
)
|
34
|
|||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
211
|
152
|
||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
154
|
$
|
186
|
||||
| |
11 | Page
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2026
|
2025
|
2026
|
2025
|
|||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(56
|
)
|
$
|
(100
|
)
|
$
|
(333
|
)
|
$
|
(296
|
)
|
||||
|
Interest expense
|
56
|
48
|
165
|
135
|
||||||||||||
|
Interest income
|
(1
|
)
|
(1
|
)
|
(3
|
)
|
(4
|
)
|
||||||||
|
Income tax provision
|
6
|
8
|
112
|
17
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
76
|
75
|
227
|
220
|
||||||||||||
|
EBITDA (non-U.S. GAAP)
|
81
|
30
|
168
|
72
|
||||||||||||
|
Gain on sale of Fuzhou (a)
|
—
|
—
|
(20
|
)
|
—
|
|||||||||||
|
Share-based compensation (b)
|
6
|
5
|
17
|
14
|
||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c)
|
5
|
6
|
15
|
20
|
||||||||||||
|
Accounts receivable securitization program (d)
|
3
|
3
|
10
|
10
|
||||||||||||
|
Foreign currency remeasurement (e)
|
2
|
—
|
16
|
(1
|
)
|
|||||||||||
|
Restructuring and other charges (f)
|
—
|
25
|
18
|
153
|
||||||||||||
|
Other items (g)
|
4
|
5
|
12
|
11
|
||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
101
|
$
|
74
|
$
|
236
|
$
|
279
|
||||||||
|
Three Months Ended September 30,
|
||||||||
|
2026
|
2025
|
|||||||
|
Net sales
|
$
|
827
|
$
|
699
|
||||
|
Net loss (U.S. GAAP)
|
$
|
(56
|
)
|
$
|
(100
|
)
|
||
|
Net loss (U.S. GAAP) as a % of Net sales
|
(6.8
|
)%
|
(14.3
|
)%
|
||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales
|
12.2
|
%
|
10.6
|
%
|
||||
|
September 30, 2026
|
December 31, 2025
|
|||||||
|
Long-term debt, net
|
$
|
3,116
|
$
|
3,132
|
||||
|
Short-term debt
|
47
|
51
|
||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
(Less) Cash and cash equivalents
|
(136
|
)
|
(199
|
)
|
||||
|
Net debt (1)
|
$
|
3,066
|
$
|
3,023
|
||||
|
Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP)
|
$
|
293
|
$
|
336
|
||||
|
Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above)
|
10.5
|
x
|
9.0
|
x
|
||||
| |
12 | Page
|
|
Nine Months Ended
September 30, 2026
|
Six Months Ended
June 30, 2026
|
Three Months Ended
September 30, 2026
|
||||||||||
|
Cash provided by operating activities
|
$
|
99
|
$
|
37
|
$
|
62
|
||||||
|
Capital expenditures
|
(169
|
)
|
(112
|
)
|
(57
|
)
|
||||||
|
Free cash flow (non-U.S. GAAP)
|
$
|
(70
|
)
|
$
|
(75
|
)
|
$
|
5
|
||||
| |
13 | Page
|
|
Three Months Ended
|
Trailing Twelve Month
Adjusted EBITDA
|
|||||||||||||||||||
|
December 31, 2025
|
March 31, 2026
|
June 30, 2026
|
September 30, 2026
|
|||||||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(177
|
)
|
$
|
(104
|
)
|
$
|
(173
|
)
|
$
|
(56
|
)
|
$
|
(510
|
)
|
|||||
|
Interest expense
|
54
|
53
|
56
|
56
|
219
|
|||||||||||||||
|
Interest income
|
(2
|
)
|
(2
|
)
|
—
|
(1
|
)
|
(5
|
)
|
|||||||||||
|
Income tax provision (benefit)
|
(2
|
)
|
—
|
106
|
6
|
110
|
||||||||||||||
|
Depreciation, depletion and amortization expense
|
82
|
75
|
76
|
76
|
309
|
|||||||||||||||
|
EBITDA (non-U.S. GAAP)
|
(45
|
)
|
22
|
65
|
81
|
123
|
||||||||||||||
|
Gain on sale of Fuzhou (a)
|
—
|
—
|
(20
|
)
|
—
|
(20
|
)
|
|||||||||||||
|
Share-based compensation (b)
|
6
|
6
|
5
|
6
|
23
|
|||||||||||||||
|
Foreign currency remeasurement (c)
|
7
|
7
|
7
|
2
|
23
|
|||||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (d)
|
(11
|
)
|
4
|
6
|
5
|
4
|
||||||||||||||
|
Accounts receivable securitization program (e)
|
3
|
3
|
4
|
3
|
13
|
|||||||||||||||
|
Restructuring and other charges (f)
|
79
|
14
|
4
|
—
|
97
|
|||||||||||||||
|
Other items (g)
|
18
|
6
|
2
|
4
|
30
|
|||||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
57
|
$
|
62
|
$
|
73
|
$
|
101
|
$
|
293
|
||||||||||
| |
14 | Page
|